Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome

Hypercytokinaemic immune dysregulation in COVID-19 is known as cytokine storm syndrome. Interleukin-6 levels ≥80 pg·mL(−1) predict an increased risk of respiratory failure and death, and immunomodulatory therapy is an area of urgent investigation. https://bit.ly/3jq3uJ4

Detalles Bibliográficos
Autores principales: Chen, Luke Y.C., Hoiland, Ryan L., Stukas, Sophie, Wellington, Cheryl L., Sekhon, Mypinder S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474149/
https://www.ncbi.nlm.nih.gov/pubmed/32883678
http://dx.doi.org/10.1183/13993003.03006-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474149/
https://www.ncbi.nlm.nih.gov/pubmed/32883678
http://dx.doi.org/10.1183/13993003.03006-2020

Ejemplares similares